
A main ingredient in the popular weight loss drugs Wegovy and Ozempic has been linked to fewer COIVD-19 deaths, according to a report.
People being treated with a 2.4 mg dose of the drug semaglutide, the active ingredient in Wegovy and Ozempic, still became infected with COVID but were 33% less likely to die, CNBC reported, citing a number of studies released last Friday by the Journal of the American College of Cardiology.